Connect Biopharma Holdings Limited Ordinary Shares (CNTB) is a publicly traded Healthcare sector company. As of September 3, 2026, CNTB trades at $2.06 with a market cap of $173.81M and a P/E ratio of -1.73. CNTB moved -30.98% today. Year to date, CNTB is -23.41%; over the trailing twelve months it is +8.43%. Its 52-week range spans $0.51 to $3.82. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces CNTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CNTB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.06 |
| Market Cap | $173.81M |
| P/E Ratio | -1.73 |
| EPS | $-1.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.82 |
| 52-Week Low | $0.51 |
| Volume | 3.50M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.95M |
| Net Income | $-68.99M |
| Gross Margin | 0.00% |
6 analysts cover CNTB: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.